Abstract. The aim of the present study is to investigate whether glycerol fructose combined with vitamin B6 is beneficial to the postoperative recovery of patients with cerebral aneurysm (CA). A total of 134 patients receiving embolization of CA in the Central Hospital of Wuhan between February, 2013 and June, 2015 and were divided into observation and control groups according to the random number table method, with 67 cases in each group. The control was given vitamin B6 routine treatment, while the observation group received glycerol fructose on the basis of treatment in the control group. The incidence rate of postoperative complications after treatment, Glasgow coma scale (GCS) score, Barthel index score, and neurological fatigue index (NFI) score were compared between the two groups. After treatment, the GCS, Barthel index and NFI scores of patients in the observation were better than those in the control group (p<0.05), and the Barthel index score in the observation group was significantly higher than that in the control group (p<0.01). The mean flow velocity of middle cerebral artery (MCA) in the observation group after treatment was significantly different from that in the control group (p<0.05). As for complications, the incidence rates of postoperative cerebral vasospasm (1.49%), cerebral ischemia (1.49%), hematoma at puncture site (2.98%) and aneurysm rupture and hemorrhage (4.47%) in the observation group were lower than those of cerebral vasospasm (8.95%), cerebral ischemia (7.46%), hematoma at puncture site (8.95%) and aneurysm rupture and hemorrhage (10.44%) in the control group, and the differences were statistically significant (p<0.05).
Introduction
Cerebral aneurysm (CA) is a kind of common cerebrovascular disease mostly affecting the elderly population. Previous findings have shown that CA ranks third in cerebrovascular diseases, and that the mortality rate of patients is on the increase currently, posing a serious threat to health and safety (1) (2) (3) . The main danger comes from the subarachnoid hemorrhage and intracranial hemorrhage caused by the rupture of the aneurysm (4) . At present, embolization is the main treatment for CA, which is fast and effective to control local hemorrhage and improve the prognosis of patients. However, postoperative complications such as cerebral vasospasm, cerebral ischemia, hematoma at puncture site, and aneurysm rupture and hemorrhage may easily lead to death and disability (5) (6) (7) .
In recent years, the effects of hyperbaric oxygen and nimodipine in the treatment of postoperative complications of CA have not been good. Glycerol fructose, as a new compound preparation, is composed of fructose, glycerin and sodium chloride. It can effectively increase plasma osmotic pressure, thereby causing dehydration to reduce intracranial pressure, and it has a long duration and low side effects. Thus, it can reduce the incidence rate of postoperative complications in patients with CA (8) . Vitamin B6, as a member of the vitamin B family, can regulate glycogen metabolism, participate in the transformation of unsaturated fatty acids and the synthesis of neural medium, and improve the postoperative mental state of patients (9) . However, there is a lack of related randomized controlled trials in clinical practice. Therefore, this study aimed to investigate glycerol fructose and vitamin B6 in the postoperative recovery of patients with CA, in order to provide a reference for clinical practice. Table I ). The study was reviewed and approved by the Ethics Committee of the Central Hospital of Wuhan, and all patients and their families were informed and provided signed written informed consent.
Materials and methods

Patient information.
Inclusion criteria for the study were: Patients diagnosed with CA by computerized tomography angiography (CTA) and digital subtraction angiography (DSA); patients with no blood relationship to each other; patients with no history of nephrotoxic drugs; patients with no autoimmune diseases of liver cirrhosis, and patients with depression, hypertension, and diabetes.
Exclusion criteria for the study were: Patients with <6 months disease; patients with drug treatment; patients 
Results
Comparisons of scores of the two groups of patients after treatment.
The GCS score of patients in the observation group after treatment (13.54±1.87) was different from that in the control group (10.67±1.48) (p<0.05). The Barthel index score in the observation group (61.33±10.31) was significantly different from that in the control group (41.77±7.34) (p<0.01). The NFI score showed that there was a difference between the control group (7.64±1.47) and the observation group (11.41±1.84) (p<0.05; Fig. 1 ).
Comparisons of the mean flow velocity of middle cerebral artery (MCA) in the two groups of patients before and after treatment.
The mean flow velocity of MCA in the observation group after treatment (140.31±35.41) was significantly different from that in the control group (123.14±25.67) (p<0.05), and there was no significant difference compared with that before treatment in the control group (p>0.05; Table II) .
Incidence rate of prognostic complications in patients. Comparisons of the incidence rate of postoperative complications between the two groups of patients showed that the incidence rates of postoperative cerebral vasospasm (1.49%), cerebral ischemia (1.49%), hematoma at puncture site (2.98%), and aneurysm rupture and hemorrhage (4.47%) in the observation group were lower than those of cerebral vasospasm (8.95%), Figure 1 . Comparisons of scores between the two groups of patients after treatment. The figure shows that, after treatment, the Barthel index score in the observation group is significantly higher than that in the control group (p<0.01), and there are statistically significant differences in the GCS and NFI scores between the observation and control groups (p<0.05). GCS, Glasgow coma scale; NFI, neurological fatigue index. cerebral ischemia (7.46%), hematoma at puncture site (8.95%), and aneurysm rupture and hemorrhage (10.44%) in the control group, and the differences were statistically significant (p<0.05; Table III ).
Discussion
The disability and mortality rates of hemorrhage caused by rupture of CA are very high. There are data indicating that nearly 30% of aneurysm patients eventually succumbed to subarachnoid hemorrhage, and nearly half of the patients had permanent neurological deficits (10) . Embolization of CA is currently the most effective treatment, but there are more postoperative complications, such as cerebral vasospasm, hydrocephalus and delayed cerebral ischemia. In particular, cerebral vasospasm is the main cause of the high disability and mortality rates caused by embolization of CA. The clinical manifestations of CA include unconsciousness, limb paralysis, neurolocation dysfunction, and high fever headache, whose CT detection is mainly manifested as abnormal lumen morphology with skull base artery continuous contraction (11) .
Glycerol fructose is a kind of high permeability dehydration compound preparation, which can improve the intravascular osmotic pressure and cause dehydration, thereby relieving the brain edema in patients. As it is a mixed preparation, its osmotic pressure is 7-fold higher than that of the human body by (12) . Glycerol fructose can increase the plasticity of red blood cells, resulting in increased oxygen supply and vascular reflex contraction, and ultimately promote the reduction of edema (13) . In addition, glycerol fructose is decomposed into H 2 O and CO 2 providing energy for the human body, and since it is not metabolised in the kidney, no damage occurs (14) . Moreover, vitamin B6, otherwise known as pyridoxine, is crucial in the metabolism of the body, as well as in the developmental and functional regulation of the healthy nervous system (15, 16) . A study has shown (17) that vitamin B6 can reduce the concentration of hemocyanins (Hcys) in patients (increase of Hcy may indicate the occurrence of other cardiovascular diseases such as atherosclerosis) and platelet aggregation, because vitamin B6 is involved in the reaction of enzymes to prevent atherosclerosis.
In this study, the recovery of patients with CA receiving glycerol fructose combined with vitamin B6 treatment was observed. The scores in each group were evaluated, and it was found that, in GCS, Barthel, and NFI scores, the disease condition of patients in each group was significantly improved after treatment compared with that before treatment, and there was a statistical difference (p<0.05). There was a significant difference in the Barthel score between the observation and control groups (p<0.01), indicating that glycerol fructose combined with vitamin B6 is a major contributor in the daily life and action of patients after embolization of CA. The mean flow velocity of MCA was detected and compared, and results showed a significant increase after treatment. However, the mean flow velocity of MCA in the control group increased more gradually than that in the observation group, and the difference was statistically significant (p<0.05). This result suggested that the combination of glycerol fructose and vitamin B6 can improve the mean flow velocity of MCA of patients, and that it is beneficial to the recovery of patients. Finally, the postoperative complications of patients were counted, and it was found that the incidence rate of postoperative complications of patients in the control group was higher than that in the observation group, and the difference was statistically significant (p<0.05), indicating that the combination of the two drugs can reduce the incidence rate of postoperative complications. Previous findings have shown that vitamin B6 can promote the synthesis of endogenous carbon monoxide (NO) and platelet-derived NO (18) (19) (20) . However, endogenous NO and platelet-derived NO can reduce platelet activation and platelet aggregation, thereby indicating that vitamin B6 can indirectly affect platelet activation and platelet aggregation, and reduce the occurrence of atherosclerosis.
There are also some limitations to this study. It is currently not known whether the number of specimens and the regional differences have an impact on this study. In future research, the results need to be improved using a larger sample.
In conclusion, glycerol fructose combined with vitamin B6 in the postoperative treatment of patients with CA was examined in this study. It was found that the combination of the two drugs can reduce the incidence rate of postoperative complications of patients and improve their quality of life. Therefore, it is beneficial to recovery and it is worthy of clinical promotion.
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